Imugene Ltd. | |
Stock Exchange | Australian Stock Exchange |
EPS |
AUD0 |
Market Cap |
AUD54.15 M |
Shares Outstanding |
3.61 B |
Public Float |
3.03 B |
Address |
62 Lygon Street Carlton Victoria (VIC) 3053 Australia |
Employees | - |
Website | http://www.imugene.com |
Updated | 07/08/2019 |
Imugene Ltd. is a biopharmaceutical company, which engages in the research, development, and commercialisation of health technologies against cancer. Its products include b-cell peptide cancer vaccines, arginine modulators, and mimotopes. The company was founded on May 30, 1986 and is headquartered in Carlton, Australia. |